Monsanto IPO to raise $100 million

15 May 2000

Pharmacia Corp's wholly-owned agricultural unit, Monsanto, has filed aregistration statement with the Securities and Exchange Commission to raise $100 million in an initial public offering.

The company will list its shares on the New York Stock Exchange, and Pharmacia will continue to own more than 80% of Monsanto's common stock. The underwriters for the offering are Goldman Sachs, Salomon Smith Barney, JP Morgan, Morgan Stanley Dean Witter, Bear Stearns & Co and Merrill Lynch.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >